Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
QLGNCompany Name
QUALIGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQQUALIGEN THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
QLGN - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ -1.65M | $ 2.98M | 0 |
| 3/31/2025 | $ 33.13K | $ 5.02M | 151.53 |
| 12/31/2024 | $ 2.68M | $ 5.58M | 2.08 |
| 9/30/2024 | $ -2.14M | $ 2.99M | 0 |
| 6/30/2024 | $ -4.28M | $ 2.47M | 0 |
| 3/31/2024 | $ -3.52M | $ 1.59M | 0 |
| 12/31/2023 | $ -2.1M | $ 2.41M | 0 |
| 9/30/2023 | $ -1.64M | $ 3.81M | 0 |
| 6/30/2023 | $ 2.03M | $ 5.31M | 2.61 |
| 3/31/2023 | $ 4.87M | $ 5.15M | 1.06 |
Key Performance Insights, Last 5 Years
- QUALIGEN THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, QUALIGEN THERAPEUTICS INC's average P/B has been 13.58.
- The median P/B for QUALIGEN THERAPEUTICS INC during this period was 2.08
- QUALIGEN THERAPEUTICS INC reached its highest P/B over the past 5 years at 151.53.
- The lowest P/B recorded by QUALIGEN THERAPEUTICS INC in the same timeframe 0.7
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for QUALIGEN THERAPEUTICS INC is calculated as follows: Market Cap [ $ 80.48M ] / Equity [ $ -2.89M ]
(=) P/B [ 0 ] QLGN - Price to Book, Last 5 years
0.7
Minimum
Dec 31, 2022
151.53
Maximum
Mar 31, 2025
13.58
Average
2.08
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |